INFECTIOUS DISEASES DIAGNOSTIC MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-171101 | Service
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Infectious Diseases Diagnostic Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET
7.1 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA INFECTIOUS DISEASES DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Becton Dickinson & Company
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Abbott Laboratories
16.3 Roche Diagnostics
16.4 Siemens Healthineers AG
16.5 DiaSorin SpA
16.6 Grifols SA
16.7 bioMerieux SA
16.8 Bio-Rad Laboratories, Inc
16.9 Quidel Corporation
16.10 Danaher Corporation
16.11 Thermo Fisher Scientific, Inc
16.12 QIAGEN
16.13 Hologic, Inc
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredBlood
Urine
Others
Major Downstream Industry Covered
Rehabilitation Centers
Diagnostic Laboratories
Hospitals and Trauma Centers
Others
Companies
Becton Dickinson & Company
Abbott Laboratories
Roche Diagnostics
Siemens Healthineers AG
DiaSorin SpA
Grifols SA
bioMerieux SA
Bio-Rad Laboratories, Inc
Quidel Corporation
Danaher Corporation
Thermo Fisher Scientific, Inc
QIAGEN
Hologic, Inc
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.